Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01232
|
|||||
| Drug Name |
Acetylcarnitine
|
|||||
| Synonyms |
(-)-Acetylcarnitine; (3R)-3-acetyloxy-4-(trimethylazaniumyl)butanoate; (R)-Acetylcarnitine; 3040-38-8; 6DH1W9VH8Q; ALCAR; Acetyl-L-(-)-carnitine; Acetyl-L-carnitine; Acetylcarnitine, L-; CAR(2:0); CHEBI:57589; Carnitine, acetyl-, L-; HSDB 7587; L-ACETYLCARNITINE; L-Acetyl carnitine; L-Carnitine acetyl ester; L-O-Acetylcarnitine; Levocarnitine acetyl; Nicetile; O-Acetyl-L-carnitine; R-Acetylcarnitine; RDHQFKQIGNGIED-MRVPVSSYSA-N; UNII-6DH1W9VH8Q; acetyl l-carnitine; acetyl-carnitine; acetylcarnitine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Migraine [ICD11: 8A80] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C9H17NO4
|
|||||
| Canonical SMILES |
CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C
|
|||||
| InChI |
InChI=1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3/t8-/m1/s1
|
|||||
| InChIKey |
RDHQFKQIGNGIED-MRVPVSSYSA-N
|
|||||
| CAS Number |
CAS 3040-38-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 203.24 | Topological Polar Surface Area | 66.4 | ||
| Heavy Atom Count | 14 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
0.4
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:57589
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCTN2 | Transporter Info | Organic cation/carnitine transporter 2 | Substrate | [2] | |
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | OCTN2 | Transporter Info | Km = 8.5 microM | Human embryonic kidney cells (HEK293)-OCTN2 | [3] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01695317) Effect of Acetyl-L-carnitine in Migraine | |||||
| 2 | Cloning and functional characterization of a novel up-regulator, cartregulin, of carnitine transporter, OCTN2. Arch Biochem Biophys. 2006 Aug 1;452(1):29-37. | |||||
| 3 | Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther. 1999 Nov;291(2):778-84. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.